Blockade of in vivo binding of 125I-labeled 3-iodobenzamide (IBZM) to dopamine receptors by D2 antagonist and agonist.

Singhaniyom, W; Tsai, Y F; Brücke, T; McLellan, C A; Cohen, R M; Kung, H F; Chiueh, C C

Singhaniyom, W; Tsai, Y F; Brücke, T; McLellan, C A; Cohen, R M; Kung, H F; Chiueh, C C.

Affiliation

Singhaniyom W; Section on Clinical Brain Imaging, National Institute of Mental Health, Bethesda, MD 20892-1000.

Brain Res ; 453(1-2): 393-6, 1988 Jun 21.

Article in En | MEDLINE | ID: mdl-2969766

Subject(s)

Benzamides/metabolism; Caudate Nucleus/metabolism; Nucleus Accumbens/metabolism; Olfactory Bulb/metabolism; Pyrrolidines/metabolism; Receptors, Dopamine/metabolism; Septal Nuclei/metabolism; Animals; Autoradiography; Binding, Competitive; Dopamine/analogs & derivatives; Dopamine/metabolism; Ergolines/metabolism; Mice; Mice, Inbred C57BL; Quinpirole; Receptors, Dopamine/drug effects; Receptors, Dopamine D2

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Olfactory Bulb / Pyrrolidines / Septal Nuclei / Benzamides / Caudate Nucleus / Receptors, Dopamine / Nucleus Accumbens Limits: Animals Language: En Journal: Brain Res Year: 1988 Type: Article

Search on Google

XML

PubMed Links